According to the new market research report “Breast Imaging Market by Technology (Ionizing (Mammography (Digital Mammography, 3D Mammogram, Analog), MBI, PET-CT, PEM), Non-ionizing (Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography)) – Global Forecast to 2023“, published by MarketsandMarkets™, the global Breast Imaging Market is projected to reach USD 4.6 billion by 2023 from USD 3.1 billion in 2018, at a CAGR of 8.0%
Don’t miss out on business opportunities in Breast Imaging Market
Technological advancements in the field of breast imaging and the rising incidence of breast cancer are the major factors driving the growth of this market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other major factors driving the growth of this market.
The ionizing breast imaging segment accounted for the largest share of the Breast Imaging Market, by technology, in 2018
Based on technology, the market is segmented into ionizing (mammography, PET-CT, MBI, and PEM) and non-ionizing (breast ultrasound, breast MRI, AWBU, and breast thermography), and other breast imaging technologies (CBCT, electrical impedance tomography, and optical imaging). The ionizing breast imaging technology segment accounted for the largest share of the Breast Imaging Market during the forecast period. The large share of this market segment is primarily due to the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.
Browse and in-depth TOC on “Breast Imaging Market“
148 – Tables
38 – Figures
198 – Pages
Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=897
3D breast tomosynthesis to register the highest CAGR in the mammography market during the forecast period
Based on type, the mammography market is classified into full-field digital mammography, 3D breast tomosynthesis, and analog mammography. The 3D breast tomosynthesis segment is expected to witness the highest CAGR during the forecast period. The growing demand for advanced screening technologies and increasing regulatory approvals for 3D breast tomosynthesis systems are the key factors driving the growth of this segment.
North America to dominate the Breast Imaging Market during the forecast period
The Breast Imaging Market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. The North American region accounted for the largest share of the Breast Imaging Market in 2018. The rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and the rapidly increasing geriatric population in the region are some of the major factors driving the growth of the Breast Imaging Market in North America.
Inquiry Before Buying:https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=897
The major players operating in the Breast Imaging Market are Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), FUJIFILM Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France).
